| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $404.3M | +0.9% |
| Cost of Revenue | $87.5M | -15.9% |
| Gross Profit | $316.9M | +6.7% |
| R&D Expense | $72.0M | +1.6% |
| SG&A Expense | $72.2M | -9.0% |
| Operating Income | -$6.2M | +90.4% |
| Pre-tax Income | -$338K | +99.5% |
| Income Tax | $2.3M | +10.2% |
| Net Income | -$2.6M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $210.2M | +10.5% |
| Accounts Receivable | $108.2M | -1.4% |
| Current Assets | $359.9M | +3.8% |
| Total Assets | $508.8M | -2.9% |
| Current Liabilities | $267.8M | -7.9% |
| Total Liabilities | $361.6M | -8.6% |
| Stockholders' Equity | $147.2M | +15.0% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $46.2M | +158.5% |
| Capital Expenditures | $2.7M | -56.0% |
| Investing Cash Flow | -$2.7M | +56.0% |
| Financing Cash Flow | -$23.3M | +70.6% |
| Free Cash Flow | $43.4M | +272.5% |
| +96.0% |
| EPS (Basic) | -$0.02 | +96.2% |
| EPS (Diluted) | -$0.02 | +96.2% |